Nu Skin Enterprises (NYSE: NUS) reported Q2 EPS of $0.21, $0.04 better than the analyst estimate of $0.17. Revenue for the quarter came in at $439.1 million versus the consensus estimate of $431.87 million.

GUIDANCE:

Nu Skin Enterprises sees Q3 2024 EPS of $0.15-$0.25, versus the consensus of $0.42. Nu Skin Enterprises sees Q3 2024 revenue of $430-465 million, versus the consensus of $459.9 million.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.